Is There Any Risk for Metabolic Syndrome in Children and Adolescents with Psychiatric Disorders?
Objective: We aimed to investigate the risk of antipsychotic drug treatment in the development of metabolic syndrome (MetS) in children and adolescents and to determine which psychiatric disorder is more associated with MetS in the pediatric population. Methods: The sample consisted of 118 children...
Saved in:
Main Authors: | Öznur Bilaç, Akın Tahıllıoğlu, Burak Çakır, Canem Kavurma, Arif Önder, Eyüp Sabri Ercan |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2023-09-01
|
Series: | Dubai Medical Journal |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/533470 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting
by: Christoph U. Correll, et al.
Published: (2025-01-01) -
The role of exercıse ın reducıng the sıde effects of antıpsıcotıcs used ın the treatment of bıpolar dısorders
by: Hatice Toy, et al.
Published: (2019-04-01) -
Quetiapine-related weight loss: Report of a rare adverse effect
by: Nicodemus Okwudili K Obayi, et al.
Published: (2018-07-01) -
Delirium is one of the many faces of COVID-19. Literature review
by: A. Bagdonaitė, et al.
Published: (2020-12-01) -
Antipsychotic-induced hyperprolactinemia: Toxicologic mechanism and the increased breast cancer risk
by: Steven B. Bird
Published: (2025-06-01)